semaj83/ctmatch_classification huggingface dataset:
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 42.0-71.0,  Influenza Capable of informed consent and provision of written informed consent before any study procedures. 2. Capable of attending all study visits according to the study schedule. 3. Males or females born between 1968-1977 or 1948-1957. 4. Are in good health, as determined by medical history and targeted physical exam related to this history. 5. Oral temperature is less than 38C. 6. Resting pulse rate is between 50 and 100 beats per minute. 7. Female subjects of childbearing age must have a negative urine pregnancy test within 24 hours before study vaccination. 8. Have received the influenza vaccine at least 3 of the past 5 years (between September 2013-June 2018) or have received the influenza vaccine in 2 or less of the past 5 years (between September 2013-June 2018)  Have an acute illness within 72 hours before vaccination. 2. Have any condition that, in the opinion of the principal investigator, would place the subject at an unacceptable risk of harm or confound the interpretation of the study results. 3. Have any acute or chronic medical condition that, in the opinion of the principal investigator, would make vaccination unsafe or interfere with the evaluation of immune response to study vaccination. 4. Have a suppressed immune system as a result of illness, immunosuppressive medication, chemotherapy, or radiation therapy within 3 years prior to study vaccination. 5. Have known HIV, hepatitis B, or hepatitis C infection. 6. Have a known history of autoimmune disease. 7. Have taken oral or parenteral corticosteroids of any dose within 30 days before study vaccination. 8. Have taken high-dose inhaled corticosteroids within 30 days before study vaccination. 9. Have received, or plan to receive, any licensed live vaccine within 30 days, or any licensed inactivated vaccine within 14 days, prior to, or after, study vaccination. 10. Have planned receipt of any unlicensed or investigational medications, biologics, or vaccines for the duration of subject study participation. 11. Have received immunoglobulin or other blood products, with the exception of Rho D immunoglobulin, within 90 days prior to study vaccination. 12. Have donated blood or blood products within 30 days before study vaccination, or within 60 days after study vaccination, or plan to donate blood within 30 days of the last blood draw. 13. Have known hypersensitivity or allergy to eggs, egg protein, chicken protein, or other compounds of the study vaccine. 14. Have a history of severe reactions following vaccination with influenza virus vaccines
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 6.0-16.0,  Vaccination Children age 6 to 16 years 2. Patients arriving to the immunization clinic for immunization. 3. Parents will sign a consent form and children will sign an assent form  Children with conditions that may prohibit participation or evaluation of the procedure (such as developmental delay) 2. Facial features or injury prohibiting wearing the VR goggles 3. VR system may interfere with immunization
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza, Vaccination Enrollment in Sendero IdealCare health plan as of August 1, 2018 Age 18 years or older  A coverage termination date listed prior to December 31, 2018 Sendero member records lack both a phone number and email address
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Influenza A Subtype H5N1 Infection Participated in Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine with and without AS03 Adjuvant study Capable of informed consent and provision of written informed consent before any study procedures Capable of attending all study visits according to the study schedule Are in good health, as determined by medical history and targeted physical exam related to this history Female subjects of childbearing age must have a negative urine pregnancy test before study vaccination, and must use at least one form of contraception to avoid pregnancy for 28 days before and 28 days after Fluarix Quadrivalent administration  Have an acute illness, including any fever (> 100.4 F [> 38 degrees C], regardless of the route) within 72 hours before vaccination Have any acute or chronic medical condition that, in the opinion of the principal investigator, would make vaccination unsafe or interfere with the evaluation of immune response to study vaccination Alcohol or drug abuse and psychiatric conditions that, in the opinion of the investigator, would preclude compliance with the trial or interpretation of safety or endpoint data Have a suppressed immune system as a result of illness, immunosuppressive medication, chemotherapy, or radiation therapy within 3 years prior to study vaccination Are pregnant or breastfeeding or plan to within one month of vaccination Have taken oral or parenteral corticosteroids of any dose within 28 days before study vaccination Have a known history of autoimmune disease Have a history of Guillain-Barre Syndrome Have a history of bleeding disorders Have known hypersensitivity or allergy to any component of the vaccine, including egg and latex allergies, or history of anaphylaxis with influenza vaccine or vaccine component
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Women With Breast Cancer the X-ray images of the breast were complete the results of pathological diagnosis or more than 2 years of mammography follow-up were available subject signs informed consent(this item was only for prospective study cases)  there exists pathological diagnosis of breast lesions when receiving mammography there lacks pathological diagnosis or 2 years of mammography follow-up subject withdraws(this item was only for prospective study cases)
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza Influenza-like Illness Eligible for care in Department of Defense medical facilities (Defense Enrollment Reporting System eligible) 2. ≥18 years of age. 3. At a participating Military Treatment Facility site for the purpose of receiving a seasonal (2018-2019, 2019-2020,2020-2021) influenza vaccination. 4. Able to speak English and able to provide informed consent 5. Able to receive and respond to texts and/or emails, or a military recruit  Adults intending to receive or who have received the current seasons FluMist Vaccine (LAIV) 2. Adults who have already received a flu vaccine within the current season 3. Individual who cannot receive a flu vaccine or standard dosing due to another medical condition 4. Allergic to gentamicin, polymyxin and/or neomycin 5. Individuals who fail to meet the
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 20.0-999.0,  Diabetes Mellitus, Type 2 Informed consent obtained before any study-related activities. Study-related activities are any procedures related to recording of data according to the protocol The decision to initiate treatment with commercially available insulin Ryzodeg® has been made by the patient/legally acceptable representative and the treating physician before and independently from the decision to the patient in this study Male or female, age more than or equal to 20 years (the legal age of adulthood) at the time of signing informed consent Diagnosed with type 2 diabetes (T2D) for at least 26 weeks prior to signing informed consent Available and documented glycosylated haemoglobin (HbA1c) value less than or equal to 12 weeks prior to initiation of Ryzodeg® treatment For at least 26 weeks prior to initiation of Ryzodeg® treatment, one of the following must apply: A) Treated with insulin glargine (IGlar) (any formulation, including biosimilar IGlar). B) Treated with IGlar (any formulation, including biosimilar IGlar) and IGlar U300 for at least 12 weeks prior to initiation of Ryzodeg®  Previous participation in this study. Participation is defined as signed informed consent Pregnancy Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation Hypersensitivity to Ryzodeg® or to any of the excipients Previously treated with Ryzodeg®
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Postoperative Pain Pregnant women at least 18 years of age 2. Gestational age > or = to 30 weeks 3. Singleton gestation 4. Women undergoing a non-emergent cesarean delivery 5. Spinal anesthesia or combined spinal-epidural anesthesia utilized during cesarean 6. Ability to undergo the informed consent process in English  Vertical skin incision 2. General anesthesia for cesarean 3. History of major depression or postpartum depression requiring medication 4. Chronic opiate use during pregnancy, defined as anyone who has taken an opioid or opioid replacement therapy in the 3 days prior to admission for delivery. This does not opioids given for labor anesthesia. 5. Magnesium sulfate treatment postpartum 6. Preexisting fibromyalgia, chronic pain syndrome, or rheumatologic disorder
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-16.0,  Diagnoses Disease childrens admitted inside Assiut university hospital with ME and fullfilling it's symptoms and signs  -Childrens with symptoms and signs that are not consistenet with ME
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Latent Tuberculosis Age 18 years + 1 day (defined as date of birth plus one day). This age cutoff has been selected as tstin3d.com has only been validated for this age group. Subjects must have all of the following Untreated Latent Tuberculosis Infection (LTBI), defined as positive Tuberculin skin test/QuantiFERON TB Gold test or T-spot assay done within 1 month prior to enrollment Absence of active TB disease as determined by history, physical examination, chest X-ray, (sputum smear and/or culture done as needed by the assessing physician for Mtb) Greater than 10% cumulative risk of developing active TB disease (determined by TSTin3D.com)  A subject will be excluded if any of the following are met Presence of active TB disease BMI <16 Cardiovascular instability (Blood pressure: Systolic >180 or <90 mm/Hg or Diastolic >100 or < 50mm/Hg; pulse <40 or >110) Chest X-Ray report within last 3 months not available HIV positive and currently on treatment with a regimen that has severe drug interactions with 3HP Presumed infected with INH or Rifapentine (RIF)-resistant M. tuberculosis Women who are pregnant, nursing or expect to become pregnant for the duration of the study Temperature ≥38.5°C or other clinical evidence of an acute infection at screening History of treatment for >14 consecutive days with a rifamycin or >30 consecutive days with isoniazid during the previous 2 years
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 40.0-69.0,  Hypertension Hypertension Complicated With Type 2 Diabetes Walking Chinese Square Dancing 40-69 years of age 2. Meet any one of the two conditions: 2.1 Hypertension: diagnosed with hypertension, systolic blood pressure is 130-159 mmHg, take no antihypertensive drug or no more than 2 kinds of antihypertensive drugs 2.2 Hypertension complicated with diabetes: diagnosed with hypertension and type 2 diabetes, systolic blood pressure is 130-159 mmHg and the fasting blood glucose in the past 2 weeks was 5.6-16.7 mmol/L (13.8-16.7 mmol/L was negative for urinary ketone) , take no more than 4 kinds of antihypertensive and hypoglycemic drugs 3. Maintain the current state of medication for the next 3 months 4. Lived in the current community in the past six months 5. Have no intention of moving out for the next three months 6. Have no regular exercise habit (moderate intensity activity less than 3 times a week, less than 30 minutes each time or 30 minutes cumulative), at least exercise 3 days a week 7. Sign informed consent  Manual works(such as farmers, couriers, athletes and workers, who rely on physical activity to make a living) 2. Physical disability that prevents patients from walking or Chinese square dancing 3. Currently enrolled in another lifestyle intervention trial(interventions such as nutrition, psychology, exercise and health education) 4. Pregnant or planning to become pregnant 5. BMI(body mass index)≥35 kg/m2 6. Answers to questions 2, 3 and 6 of the questionnaire in 2014PAR-Q+ are "yes" 7. Cardio-cerebrovascular events have occurred in the past 6 months(heart disease diagnosed by doctors, such as coronary heart disease, hypertensive heart disease, acute myocarditis, pulmonary heart disease, etc.) 8. Fasting blood glucose of diabetic patients is 13.8-16.7 mmol/L and urinary ketone is positive 9. Severe complications of diabetes affecting exercise , such as foot, eye disease and renal insufficiency 10. Complicated with other serious chronic diseases such as asthma, malignant tumor, chronic heart failure, severe depression or other mental disorders
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 50.0-999.0,  Aging Fall years of age or older Can exercise with minimal supervision (cleared for physical activity) Can commit to a 12-week exercise program (2 sessions/week)  Under 50 years of age Not cleared to perform physical activity
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 35.0-75.0,  Renal Transplantation Aging are group specific. HBV, HCV and HIV testing are not necessary in the RT groups as all RT recipients are tested prior to transplant. The investigators will not restrict volunteers with respect to gender, ethnic or racial group. Groups 1 (65-75 yrs) and 2 (35-45 yrs) Renal Transplant populations End stage renal disease cause either DM2 and/or hypertension (HTN) Renal transplant >12 months ago Group 3: Diabetic/hypertensive 65-75 year old controls With DM2 and/or HTN Previous immunization with PPV23 >1 year prior Willingness to be tested for HIV, HBV and HCV "normal kidney function" defined as glomerular filtration rate (GFR) of 60% or above Group 4: Healthy Control 65-75 yr old Without DM2 May have high blood pressure (systolic>140 and/or diastolic>90) as long as it is well controlled (systolic<140 and/or diastolic <90) and has not affected kidney function Previous receipt of PPV23 > 1 year prior  are either applicable to all groups or group specific. Therefore we have listed the applicable to ALL groups first. Group specific are listed under each group common to all groups Previous immunization with PCV13 Pregnancy, no contraceptive practice in women of childbearing age, or breastfeeding Known anaphylaxis, hypersensitivity or "bad allergic reaction" to the pneumonia vaccine. This does not egg allergy or previous Guillan Barre syndrome Those who received blood products or gamma globulin within 3 months Inability to comprehend or sign the informed consent form Previous/present illness that may affect immune response to the vaccine previous pneumococcal disease
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Diabetes Mellitus, Type 2 Signed informed consent obtained before any study-related activities (study-related activities are any procedures related to recording of data according to protocol) Male or female, age more than or equal to 18 years at the time of signing informed consent (in Algeria more than or equal to 19 years; in Japan more than or equal to 20 years) Diagnosed with T2DM more than or equal to 180 days prior to the day of signing the informed consent  Previous participation in this study. Participation is defined as having given informed consent in this study Diagnosed with Type 1 diabetes Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation Patients with known congenital heart disease/malformation
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 60.0-80.0,  Stage 4 Chronic Kidney Disease Patients with diabetic nephropathy in stage 4 chronic kidney disease Patients in pre-dialysis Patients with signed informed consent forms  Patients who have received Ketosteril previously Patients participating in other intervention studies Pregnant women Patients with background of renal transplant Patients with cancer, HIV, seropositive for hepatitis B or C or receiving immunosuppressors, hypercalcemia Intolerance of Ketosteril ingredients Hereditary disorders in amino acid metabolism
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 60.0-999.0,  Quality of Life Aging No medical contraindications to be involved in the exercise programs To be able to follow the exercise classes Signed informed consent
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Pain Management Any patient undergoing laparoscopic hysterectomy Benign indications Dr. Jamal Mourad or Dr. Nichole Mahnert will be performing hysterectomy  Non-English speakers History of chronic opioid use History of epilepsy History of claustrophobia Have received a prescription or taken opioids within 2 weeks for their scheduled surgery